Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2014

01.05.2014 | Clinical Trial

Accuracy of ultrasound-guided breast-conserving surgery in the determination of adequate surgical margins

verfasst von: Holm Eggemann, Tanja Ignatov, Serban Dan Costa, Atanas Ignatov

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

The goal of this study was to assess the size of the ultrasound-measured margin associated with an adequate surgical margin during breast-conserving surgery (BCS). The study was designed as a prospective cohort study. Patients with primary invasive breast cancer undergoing BCS were included. The ultrasound-measured surgical margins were compared with the pathological margins. 147 patients were eligible for analysis. 21 (14.3 %) patients had close or positive resection margins and 13 (8.8 %) underwent a second operation. Small excision volume, multifocality, postmenopausal status, high grade tumor-associated intraductal component, and invasion of lymph vessels and lymph nodes were associated with increased risk of positive excision margins. In the study cohort, 882 Ultrasonography (US) margins were measured and a good correlation to the pathological margins was observed. Overestimation of the US-measured margins relative to the pathological margins was increased with younger age, premenopausal status, and intraductal component. The estimated positive and negative predictive values, sensitivity and specificity were 81.0, 96.2, 48.4, and 99.1 %, respectively. We found that a sonographically estimated margin of ≥4 mm was associated with an adequate pathological margin of ≥1 mm in 100 % of tumors that did not have a high grade intraductal component. However, this was not applicable for tumor-associated high grade intraductal component where a US margin of 14 mm was associated with clear pathological margins in 100 % of cases. Intraoperative ultrasonography is a safe and feasible method to obtain clear surgical margins by BCS.
Literatur
1.
Zurück zum Zitat Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227–1232PubMedCrossRef Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227–1232PubMedCrossRef
2.
Zurück zum Zitat Luini A, Rososchansky J, Gatti G, Zurrida S, Caldarella P, Viale G, dos Rosali SG, Frasson A (2009) The surgical margin status after breast-conserving surgery: discussion of an open issue. Breast Cancer Res Treat 113:397–402PubMedCrossRef Luini A, Rososchansky J, Gatti G, Zurrida S, Caldarella P, Viale G, dos Rosali SG, Frasson A (2009) The surgical margin status after breast-conserving surgery: discussion of an open issue. Breast Cancer Res Treat 113:397–402PubMedCrossRef
4.
Zurück zum Zitat Ahmed M, Douek M (2013) Intra-operative ultrasound versus wire-guided localization in the surgical management of non-palpable breast cancers: systematic review and meta-analysis. Breast Cancer Res Treat 140:435–446PubMedCrossRef Ahmed M, Douek M (2013) Intra-operative ultrasound versus wire-guided localization in the surgical management of non-palpable breast cancers: systematic review and meta-analysis. Breast Cancer Res Treat 140:435–446PubMedCrossRef
5.
Zurück zum Zitat Fisher CS, Mushawah FA, Cyr AE, Gao F, Margenthaler JA (2011) Ultrasound-guided lumpectomy for palpable breast cancers. Ann Surg Oncol 18:3198–3203PubMedCrossRef Fisher CS, Mushawah FA, Cyr AE, Gao F, Margenthaler JA (2011) Ultrasound-guided lumpectomy for palpable breast cancers. Ann Surg Oncol 18:3198–3203PubMedCrossRef
6.
Zurück zum Zitat Moore MM, Whitney LA, Cerilli L, Imbrie JZ, Bunch M, Simpson VB, Hanks JB (2001) Intraoperative ultrasound is associated with clear lumpectomy margins for palpable infiltrating ductal breast cancer. Ann Surg 233:761–768PubMedCentralPubMedCrossRef Moore MM, Whitney LA, Cerilli L, Imbrie JZ, Bunch M, Simpson VB, Hanks JB (2001) Intraoperative ultrasound is associated with clear lumpectomy margins for palpable infiltrating ductal breast cancer. Ann Surg 233:761–768PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Olsha O, Shemesh D, Carmon M, Sibirsky O, Abu DR, Rivkin L, Ashkenazi I (2011) Resection margins in ultrasound-guided breast-conserving surgery. Ann Surg Oncol 18:447–452PubMedCrossRef Olsha O, Shemesh D, Carmon M, Sibirsky O, Abu DR, Rivkin L, Ashkenazi I (2011) Resection margins in ultrasound-guided breast-conserving surgery. Ann Surg Oncol 18:447–452PubMedCrossRef
8.
Zurück zum Zitat Krekel NM, Haloua MH, Lopes Cardozo AM, de Wit RH, Bosch AM, de Widt-Levert LM, Muller S, van der Veen H, Bergers E, de Lange de Klerk ES, Meijer S, van den Tol MP (2013) Intraoperative ultrasound guidance for palpable breast cancer excision (COBALT trial): a multicentre, randomised controlled trial. Lancet Oncol 14:48–54PubMedCrossRef Krekel NM, Haloua MH, Lopes Cardozo AM, de Wit RH, Bosch AM, de Widt-Levert LM, Muller S, van der Veen H, Bergers E, de Lange de Klerk ES, Meijer S, van den Tol MP (2013) Intraoperative ultrasound guidance for palpable breast cancer excision (COBALT trial): a multicentre, randomised controlled trial. Lancet Oncol 14:48–54PubMedCrossRef
9.
Zurück zum Zitat Schwartz GF, Goldberg BB, Rifkin MD, D’Orazio SE (1988) Ultrasonography: an alternative to X-ray-guided needle localization of nonpalpable breast masses. Surgery 104:870–873PubMed Schwartz GF, Goldberg BB, Rifkin MD, D’Orazio SE (1988) Ultrasonography: an alternative to X-ray-guided needle localization of nonpalpable breast masses. Surgery 104:870–873PubMed
10.
Zurück zum Zitat Davis KM, Hsu CH, Bouton ME, Wilhelmson KL, Komenaka IK (2011) Intraoperative ultrasound can decrease the re-excision lumpectomy rate in patients with palpable breast cancers. Am Surg 77:720–725PubMed Davis KM, Hsu CH, Bouton ME, Wilhelmson KL, Komenaka IK (2011) Intraoperative ultrasound can decrease the re-excision lumpectomy rate in patients with palpable breast cancers. Am Surg 77:720–725PubMed
11.
Zurück zum Zitat Krekel NM, Lopes Cardozo AM, Muller S, Bergers E, Meijer S, van den Tol MP (2011) Optimising surgical accuracy in palpable breast cancer with intra-operative breast ultrasound—feasibility and surgeons’ learning curve. Eur J Surg Oncol 37:1044–1050PubMedCrossRef Krekel NM, Lopes Cardozo AM, Muller S, Bergers E, Meijer S, van den Tol MP (2011) Optimising surgical accuracy in palpable breast cancer with intra-operative breast ultrasound—feasibility and surgeons’ learning curve. Eur J Surg Oncol 37:1044–1050PubMedCrossRef
12.
Zurück zum Zitat Rahusen FD, Bremers AJ, Fabry HF, van Amerongen AH, Boom RP, Meijer S (2002) Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol 9:994–998PubMedCrossRef Rahusen FD, Bremers AJ, Fabry HF, van Amerongen AH, Boom RP, Meijer S (2002) Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol 9:994–998PubMedCrossRef
13.
Zurück zum Zitat Hieken TJ, Harrison J, Herreros J, Velasco JM (2001) Correlating sonography, mammography, and pathology in the assessment of breast cancer size. Am J Surg 182:351–354PubMedCrossRef Hieken TJ, Harrison J, Herreros J, Velasco JM (2001) Correlating sonography, mammography, and pathology in the assessment of breast cancer size. Am J Surg 182:351–354PubMedCrossRef
14.
Zurück zum Zitat Shoma A, Moutamed A, Ameen M, Abdelwahab A (2006) Ultrasound for accurate measurement of invasive breast cancer tumor size. Breast J 12:252–256PubMedCrossRef Shoma A, Moutamed A, Ameen M, Abdelwahab A (2006) Ultrasound for accurate measurement of invasive breast cancer tumor size. Breast J 12:252–256PubMedCrossRef
15.
Zurück zum Zitat Ramos M, Diaz JC, Ramos T, Ruano R, Aparicio M, Sancho M, Gonzalez-Orus JM (2013) Ultrasound-guided excision combined with intraoperative assessment of gross macroscopic margins decreases the rate of reoperations for non-palpable invasive breast cancer. Breast 22:520–524PubMedCrossRef Ramos M, Diaz JC, Ramos T, Ruano R, Aparicio M, Sancho M, Gonzalez-Orus JM (2013) Ultrasound-guided excision combined with intraoperative assessment of gross macroscopic margins decreases the rate of reoperations for non-palpable invasive breast cancer. Breast 22:520–524PubMedCrossRef
Metadaten
Titel
Accuracy of ultrasound-guided breast-conserving surgery in the determination of adequate surgical margins
verfasst von
Holm Eggemann
Tanja Ignatov
Serban Dan Costa
Atanas Ignatov
Publikationsdatum
01.05.2014
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2014
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-2932-8

Weitere Artikel der Ausgabe 1/2014

Breast Cancer Research and Treatment 1/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.